Copyright Reports & Markets. All rights reserved.

Global Celecoxib Market Insights and Forecast to 2027

Buy now

1 Study Coverage

  • 1.1 Celecoxib Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Celecoxib Market Size Growth Rate by Type
    • 1.4.2 50mg
    • 1.4.3 100mg
    • 1.2.4 200mg
    • 1.2.5 400mg
  • 1.3 Market by Application
    • 1.3.1 Global Celecoxib Market Size Growth Rate by Application
    • 1.3.2 Rheumatoid arthritis
    • 1.3.3 osteoarthritis
    • 1.3.4 Acute pain
    • 1.3.5 Musculoskeletal pain
    • 1.3.6 Other diseases
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Celecoxib Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Celecoxib Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Celecoxib Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Celecoxib Regions by Sales
    • 2.4.1 Global Top Celecoxib Regions by Sales (2016-2021)
    • 2.4.2 Global Top Celecoxib Regions by Sales (2022-2027)
  • 2.5 Global Top Celecoxib Regions by Revenue
    • 2.5.1 Global Top Celecoxib Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Celecoxib Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Celecoxib Sales by Manufacturers
    • 3.1.1 Global Top Celecoxib Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Celecoxib Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Celecoxib Sales in 2020
  • 3.2 Global Celecoxib Revenue by Manufacturers
    • 3.2.1 Global Top Celecoxib Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Celecoxib Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Celecoxib Revenue in 2020
  • 3.3 Global Celecoxib Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Celecoxib Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Celecoxib Sales by Type
    • 4.1.1 Global Celecoxib Historical Sales by Type (2016-2021)
    • 4.1.2 Global Celecoxib Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Celecoxib Sales Market Share by Type (2016-2027)
  • 4.2 Global Celecoxib Revenue by Type
    • 4.2.1 Global Celecoxib Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Celecoxib Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Celecoxib Revenue Market Share by Type (2016-2027)
  • 4.3 Global Celecoxib Price by Type
    • 4.3.1 Global Celecoxib Price by Type (2016-2021)
    • 4.3.2 Global Celecoxib Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Celecoxib Sales by Application
    • 5.1.1 Global Celecoxib Historical Sales by Application (2016-2021)
    • 5.1.2 Global Celecoxib Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Celecoxib Sales Market Share by Application (2016-2027)
  • 5.2 Global Celecoxib Revenue by Application
    • 5.2.1 Global Celecoxib Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Celecoxib Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Celecoxib Revenue Market Share by Application (2016-2027)
  • 5.3 Global Celecoxib Price by Application
    • 5.3.1 Global Celecoxib Price by Application (2016-2021)
    • 5.3.2 Global Celecoxib Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Celecoxib Market Size by Type
    • 6.1.1 North America Celecoxib Sales by Type (2016-2027)
    • 6.1.2 North America Celecoxib Revenue by Type (2016-2027)
  • 6.2 North America Celecoxib Market Size by Application
    • 6.2.1 North America Celecoxib Sales by Application (2016-2027)
    • 6.2.2 North America Celecoxib Revenue by Application (2016-2027)
  • 6.3 North America Celecoxib Market Size by Country
    • 6.3.1 North America Celecoxib Sales by Country (2016-2027)
    • 6.3.2 North America Celecoxib Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Celecoxib Market Size by Type
    • 7.1.1 Europe Celecoxib Sales by Type (2017-2027)
    • 7.1.2 Europe Celecoxib Revenue by Type (2017-2027)
  • 7.2 Europe Celecoxib Market Size by Application
    • 7.2.1 Europe Celecoxib Sales by Application (2017-2027)
    • 7.2.2 Europe Celecoxib Revenue by Application (2017-2027)
  • 7.3 Europe Celecoxib Market Size by Country
    • 7.3.1 Europe Celecoxib Sales by Country (2017-2027)
    • 7.3.2 Europe Celecoxib Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Celecoxib Market Size by Type
    • 8.1.1 Asia Pacific Celecoxib Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Celecoxib Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Celecoxib Market Size by Application
    • 8.2.1 Asia Pacific Celecoxib Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Celecoxib Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Celecoxib Market Size by Region
    • 8.3.1 Asia Pacific Celecoxib Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Celecoxib Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Celecoxib Market Size by Type
    • 9.1.1 Latin America Celecoxib Sales by Type (2019-2027)
    • 9.1.2 Latin America Celecoxib Revenue by Type (2019-2027)
  • 9.2 Latin America Celecoxib Market Size by Application
    • 9.2.1 Latin America Celecoxib Sales by Application (2019-2027)
    • 9.2.2 Latin America Celecoxib Revenue by Application (2019-2027)
  • 9.3 Latin America Celecoxib Market Size by Country
    • 9.3.1 Latin America Celecoxib Sales by Country (2019-2027)
    • 9.3.2 Latin America Celecoxib Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Celecoxib Market Size by Type
    • 6.1.1 Middle East and Africa Celecoxib Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Celecoxib Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Celecoxib Market Size by Application
    • 6.2.1 Middle East and Africa Celecoxib Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Celecoxib Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Celecoxib Market Size by Country
    • 6.3.1 Middle East and Africa Celecoxib Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Celecoxib Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 UAE

11 Company Profiles

  • 11.1 Pfizer Inc
    • 11.1.1 Pfizer Inc Corporation Information
    • 11.1.2 Pfizer Inc Overview
    • 11.1.3 Pfizer Inc Celecoxib Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Pfizer Inc Celecoxib Product Description
    • 11.1.5 Pfizer Inc Related Developments
  • 11.2 Teva
    • 11.2.1 Teva Corporation Information
    • 11.2.2 Teva Overview
    • 11.2.3 Teva Celecoxib Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 Teva Celecoxib Product Description
    • 11.2.5 Teva Related Developments
  • 11.3 Mylan
    • 11.3.1 Mylan Corporation Information
    • 11.3.2 Mylan Overview
    • 11.3.3 Mylan Celecoxib Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Mylan Celecoxib Product Description
    • 11.3.5 Mylan Related Developments
  • 11.4 Apotex
    • 11.4.1 Apotex Corporation Information
    • 11.4.2 Apotex Overview
    • 11.4.3 Apotex Celecoxib Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Apotex Celecoxib Product Description
    • 11.4.5 Apotex Related Developments
  • 11.5 Lupin
    • 11.5.1 Lupin Corporation Information
    • 11.5.2 Lupin Overview
    • 11.5.3 Lupin Celecoxib Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Lupin Celecoxib Product Description
    • 11.5.5 Lupin Related Developments
  • 11.6 Hengrui Medicine
    • 11.6.1 Hengrui Medicine Corporation Information
    • 11.6.2 Hengrui Medicine Overview
    • 11.6.3 Hengrui Medicine Celecoxib Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Hengrui Medicine Celecoxib Product Description
    • 11.6.5 Hengrui Medicine Related Developments
  • 11.1 Pfizer Inc
    • 11.1.1 Pfizer Inc Corporation Information
    • 11.1.2 Pfizer Inc Overview
    • 11.1.3 Pfizer Inc Celecoxib Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Pfizer Inc Celecoxib Product Description
    • 11.1.5 Pfizer Inc Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Celecoxib Value Chain Analysis
  • 12.2 Celecoxib Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Celecoxib Production Mode & Process
  • 12.4 Celecoxib Sales and Marketing
    • 12.4.1 Celecoxib Sales Channels
    • 12.4.2 Celecoxib Distributors
  • 12.5 Celecoxib Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Celecoxib Industry Trends
  • 13.2 Celecoxib Market Drivers
  • 13.3 Celecoxib Market Challenges
  • 13.4 Celecoxib Market Restraints

14 Key Findings in The Global Celecoxib Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Celecoxib market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Celecoxib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    50mg
    100mg
    200mg
    400mg

    Segment by Application
    Rheumatoid arthritis
    osteoarthritis
    Acute pain
    Musculoskeletal pain
    Other diseases

    By Company
    Pfizer Inc
    Teva
    Mylan
    Apotex
    Lupin
    Hengrui Medicine

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now